Lv3
350 积分 2022-10-14 加入
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
15小时前
待确认
Defining ‘chromosomal instability’
10天前
已完结
Targeting chromosomal instability in patients with cancer
11天前
已完结
141 (PB129): Discovery of a novel KAT6A/B inhibitor with anti-tumor activity coupled with novel response biomarkers
12天前
已完结
Aneuploidy as a promoter and suppressor of malignant growth
15天前
已完结
An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines
18天前
已完结
慢性咳嗽临床研究年度进展2023
26天前
已完结
慢性咳嗽年度进展2024
26天前
已完结
咳嗽基层诊疗指南(2018年)
26天前
已完结
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
1个月前
已完结
皖公网安备34019202002308
